Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
GD2-Targeted Immunotherapy of Neuroblastoma
Introduction Cancer immunotherapy has been hailed as a potential “game changer” in the treatment of cancer. However, the number of antigen targets proven effective remains limited and is restricted to protein antigens, with the exception of Dinutuximab, a chimeric antibody…